TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Ann: Regulatory Update , page-3

  1. Patrolly
    2,893 Posts.
    lightbulb Created with Sketch. 73
    clock Created with Sketch.
    18/03/13
    09:31
    Post #: 11550961
    here lies the problem

    The EMA approval process excludes sponsor companies like Tissue Therapies from direct
    contact with the EMA. The Company has been entirely dependent on BSI to make the
    submissions and to keep it informed.

    the process is flawed
    TIS Price at posting: 24.3¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.